Key facts
- This page summarizes Stuart W. Pratt's Form 4 filing for Danimer Scientific, Inc. (DNMRQ).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jun 2024, 17:00.
Stuart W. Pratt - 01 Jun 2024 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)
- Reporting relationship
- Director
- Issuer ticker
- DNMRQ
- Reported as of
- 01 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Jun 2024, 17:00:07 UTC
- Prior SEC filing
- 05 Jun 2023
- Next SEC filing
- 22 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen A. Martin, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Stuart W. Pratt filed Form 4 for Danimer Scientific, Inc. (DNMRQ) on 04 Jun 2024.
Change
- Previous filing in this sequence was filed on 05 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DNMR
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +16,611
- Change %
- +1.2%
- Price
- $0.000000
- Shares after
- 1,450,717
- Date
- 01 Jun 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DNMR
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -16,611
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 01 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 16,611
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Danimer Scientific Class A common stock.
Footnote F2
Comprised of an award of restricted stock units (RSU) granted as director compensation under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan") with each RSU representing the right to receive one share of Danimer Scientific Class A Common Stock. All of these RSU's will vest and become non-forfeitable on June 1, 2024 subject to recipient's continued service as a director of the Company.